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Abstract
Background: The number of dental implant treatments increases annually. Dental implants are manufactured by competing
companies. Systematic reviews and meta-analysis have shown a clear association between pharmaceutical industry funding
of clinical trials and pro-industry results. So far, the impact of industry sponsorship on the outcomes and conclusions of
dental implant clinical trials has never been explored. The aim of the present study was to examine financial sponsorship of
dental implant trials, and to evaluate whether research funding sources may affect the annual failure rate.
Methods and Findings: A systematic approach was used to identify systematic reviews published between January 1993
and December 2008 that specifically deal with the length of survival of dental implants. Primary articles were extracted from
these reviews. The failure rate of the dental implants included in the trials was calculated. Data on publication year, Impact
Factor, prosthetic design, periodontal status reporting, number of dental implants included in the trials, methodological
quality of the studies, presence of a statistical advisor, and financial sponsorship were extracted by two independent
reviewers (kappa =0.90; CI95% [0.77–1.00]). Univariate quasi-Poisson regression models and multivariate analysis were used
to identify variables that were significantly associated with failure rates. Five systematic reviews were identified from which
41 analyzable trials were extracted. The mean annual failure rate estimate was 1.09%.(CI95% [0.84–1.42]). The funding source
was not reported in 63% of the trials (26/41). Sixty-six percent of the trials were considered as having a risk of bias (27/41).
Given study age, both industry associated (OR=0.21; CI95% [0.12–0.38]) and unknown funding source trials (OR=0.33; (CI95%
[0.21–0.51]) had a lower annual failure rates compared with non-industry associated trials. A conflict of interest statement
was disclosed in 2 trials.
Conclusions: When controlling for other factors, the probability of annual failure for industry associated trials is significantly
lower compared with non-industry associated trials. This bias may have significant implications on tooth extraction decision
making, research on tooth preservation, and governmental health care policies.
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Introduction
Despite the paucity of epidemiological studies on edentulism in
many countries, partial and/or complete edentulism data indicate
that patients eligible to receive dental prosthesis remain numerous
worldwide [1]. It has been shown that tooth replacement improves
the quality of life in edentulous patients [2,3]. Therefore, tooth
replacement is still of paramount importance in health care, even
if tremendous efforts have been made by dental researchers in
cariology and periodontology to treat and prevent the two main
causes of edentulism: dental caries and periodontal diseases [4].
Until the discovery of the osseointegrated implants at the end of
the seventies [5], traditional removable dentures or tooth-
supported fixed dentures (dental bridges) were universally used
to replace missing teeth. However, root-form endosseous dental
implants – surgically implantable medical devices aiming to
support artificial tooth or group of teeth – have tended to replace
the traditional approach. The main reason for the widespread
indications of dental implants by practitioners should ideally be the
low percentage of annual implant loss, as demonstrated by
primary studies and recent systematic reviews and meta-analysis
[6–10]. In addition, biological reasons, i.e. the preservation of the
integrity of the teeth bordering the edentulous area, and
economical reasons, i.e. the cost-effectiveness approach showing
that implant therapy could be more cost-effective than traditional
dental bridge therapy [11,12], may be advocated. From the
patient’s point of view, dental implants are more popular than
removable dentures or dental bridges because they can offer fixed
solutions when traditional tooth replacement therapies cannot.
Therefore, osseointegrated implant discovery has completely
changed the therapeutic approach of tooth replacement. Today, 3
journals are integrally dedicated to implant dentistry, and one of
them is in the top 10 of the 55 impact factor dental journals.
Nevertheless, due to the lack of comparative trials, there is still no
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traditional therapy, and that one implant brand is more effective
than another.
The number of dentists placing dental implants is increasing
annually. Estimates indicate that the number of dental implant
procedures performed in Europe increased to 3,527,000 in 2008,
representing 8.1% growth over 2007 [13]. Markets for dental
implants have been estimated at $3.4 billion in 2008, and are
anticipated to reach $8.1 billion by 2015 [14]. Implant companies
are traded on the stock exchange. Dental implants are manufac-
tured by competing companies. In Europe, 4 companies capture
close to 60% of the market [13].
Systematic reviews and meta-analysis have shown a clear
association between pharmaceutical industry funding of clinical
trials and pro-industry results [15,16]. So far, to our knowledge,
the impact of dental industry sponsorship on the outcomes and
conclusions of clinical trials has never been explored. As shown
above, dental implant therapy appears to be an interesting
example when investigating the influence of funding source on
study results. A sponsorship bias in oral implant research may have
an adverse effect, not only on preventive dental research but also
on teeth preservation. Traditional prosthetic approaches such as
tooth-supported fixed dentures need to preserve the teeth;
whereas, dental implant therapies require edentulous areas, which
are the result of tooth loss. Therefore, in light of the high
percentage of success of implant therapy, dentists may be incited
to extract teeth instead of making efforts to preserve dental organs.
The aim of the present study was to examine financial
sponsorship of dental implant articles, and to determine whether
research funding source may affect the annual failure rate. We
hypothesized that articles exclusively or partially funded by
implant companies are more likely to report lower annual failure
rates than articles without industry-associated sponsorship.
Methods
Study selection
We included only primary articles from systematic reviews that
specifically deal with the length of survival of dental implants. The
following factors were examined: publication year (available from
Medline), Impact Factor, prosthetic design, periodontal status
reporting, the number of dental implants included in the studies,
methodological quality of the studies, the presence of a statistical
advisor, and the financial sponsorship. Study design, sample size,
dental implant brand, corresponding author country, and conflict
of interest were recorded for descriptive statistics of the sample.
More details on the selection of these factors are given below in the
‘‘Data extraction’’ section. We looked for papers published only in
English.
Search strategy
Two independent reviewers (A.P. and O.F.) searched MED-
LINE and the Cochrane database of systematic reviews to identify
systematic review articles published between January 1993 and
December 2008. The MEDLINE search was conducted using the
following MeSH terms exploded: ‘‘Dental Implants’’ and ‘‘Den-
ture, Partial, Fixed’’, in combination with ‘survival’, ‘success’ or
‘complications’ (Table S1). The search was limited to ‘‘reviews’’,
‘‘meta-analysis’’, and ‘‘humans’’. In addition, hand searching was
conducted in the following dental journals: Journal of Periodontology,
International Dental Journal, British Dental Journal, Journal of the
International Academy of Periodontology, Journal Canadian Dental
Association, Swedish Dental Journal, Quintessence International, Journal of
Clinical Periodontology, Periodontology 2000, Clinical Oral Implant
Research, International Journal of Oral and Maxillofacial Implants,
International Journal of Prosthodontic, Journal of Prosthetic Dentistry.
Inclusion and exclusion criteria
Systematic reviews. Systematic reviews with or without
meta-analysis, had to report or to allow for the calculation of the
pooled survival rate or the estimated survival rate of dental
implants. Implant-supported single crown (IS-SC), implant-
supported fixed partial denture (IS-FPD) and implant-tooth
supported fixed partial denture (ITS-FPD) were the only
prosthetic designs that were included in the present study.
Studies included in the articles had to have a mean follow-up of
at least 5 years and less than 10 years. We choose a minimum
mean follow-up of 5 years because it corresponds to the best
scientific evidence in implant dentistry [9]. Our data included
different types of dental implants studies because there is no
evidence that any specific type of dental implant has superior
survival [17].
Fully edentulous patients were excluded from our research. The
following dental implants were eliminated from the database
because of the suggested increased failure rate: immediate and
immediate-delayed dental implants; early and immediate load
dental implants; dental implants placed after sinus lift procedures
[18–20].
Primary articles. The same inclusion/exclusion criteria as
those used for the systematic review selection was applied for the
primary article selection. Data cleaning was applied to the
identification of duplicate publications on the same patient
cohorts. When the same cohort was analyzed twice at different
follow-up times, the article reporting a mean follow-up closest to 5
years was included.
Data extraction
Data were extracted from the papers included in the final
sample. Two independent investigators were involved in the
process of extraction (A.P. and O.F.). In the case of disagreement,
the two investigators discussed the article and tried to find
agreement. When consensus was not reached, a third investigator
(P.B.) was involved until agreement was found. The data were
extracted on the following publication characteristics:
Journal and authors characteristics. For each article, we
documented the name of the journal, the year of publication, and
the impact factor for the year prior to publication using the
Journal of citation reports. When the journal was not indexed, it
was assigned a ‘‘0’’ value. The country of origin of the
corresponding author was obtained from the article. The conflict
of interest statements were also recorded.
Study characteristics. The study design of each article was
identified as retrospective or prospective. Included studies were
submitted to quality assessment according to the following three
main criteria: (1) Inclusion/exclusion criteria, (2) Blindness of the
examiner, and (3) Drop-out rates. Criteria 1 and 2 were
categorized as the following: (1) ‘‘Yes’’; (2) ‘‘No’’, when it was
specified that the criteria was not used; (3) ‘‘Unclear’’, when the
article did not mentioned the criteria. The third criterion (drop-
out rate) was categorized as ‘‘Yes’’ if reported or ‘‘Unclear’’ if not
reported. The studies were evaluated as having low risk of bias if at
least 2 quality criteria were met; in all other cases the studies were
evaluated as having a risk of bias. It was also noted and recorded if
an author served as a statistical advisor or if a statistical advisor
was indicated in the article. The prosthetic designs were recorded
according to three categories: (1) implant-supported single crown
(IS-SC), (2) implant-supported fixed partial denture (IS-FPD), and
(3) implant-tooth supported fixed partial denture (ITS-FPD).
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were recorded.
Sample characteristics. In each trial, the number of
inserted dental implants and the number of implant losses, as
well as the mean follow-up, were recorded. Dental implant brands
were also identified in each article.
Funding source identification. The funding source of each
published study was categorized as follows: (1) industry, (2)
industry-associated, (3) non-industry, and (4) unknown. The study
was categorized as ‘‘industry’’ when it was clearly stated that it was
only supported by grants from an implant company, and
‘‘industry-associated’’ when the implant company had a role in
the study design (i.e. data collection or analysis, decision to
publish, preparation of the manuscript) or in free dental implant
providing. The ‘‘non-industry’’ category included studies
supported by grants from universities, governmental agencies,
independent foundations, and other nonprofits organizations with
no industry association. Each institution classified as ‘‘non-
industry’’ was carefully verified through Internet searches. When
the information was doubtful or not available, the institution was
contacted by e-mail. When no information was given on
sponsorship, the funding source was categorized as ‘‘unknown’’.
Statistical analysis
Collected data were organized into a spreadsheet using a
computer program (Excel, Microsoft, Redmond, WA). After
proofing for entry errors, the database was locked and loaded in
statistical software program by a statistician (F.V.) blind to the
study selection and data extraction. The industry and industry-
associated funding-source categories were collapsed for the
analysis. All statistical analyses were performed with R 2.10.0
software (R Foundation for Statistical Computing, Vienna,
Austria) on PC architecture.
Descriptive statistics were reported as numbers and percentages.
The Kappa statistic [21] was used to assess interrater reliability
between the two independent reviewers (A.P. and O.F.) using the
funding source scale.
The total exposure time of each included study selected from
systematic reviews was used for the 5-year estimated survival rate
calculation. Failure rate was calculated by dividing the number of
events (implant loss) in the numerator by the total exposure time in
the denominator [9,10,22]. Implant loss was extracted from the
publications. The total exposure time was calculated by the sum of
i) exposure time of implants followed for the whole observation
period, ii) exposure time of the implants lost during the
observation period, and iii) exposure time of the implants that
did not complete the observation period. Exact CI95% for failure
rate estimates was calculated using the relationship between
Poisson and Chi-square distributions [23]. Five-year survival
proportions were calculated via the relationship between event
rate and survival function S [S(T) = exp(-T x event rate)] by
assuming constant event rates [24].
The total number of events was considered to be Poisson
distributed for a given sum of implant exposure years. The Poisson
regression model, with a logarithmic link-function and a total
exposure time per study as an offset variable, was used [25]. We
used Breslow’s recommendation to detect overdispersion [26], and
a quasi-Poisson model for handling heterogeneity [25].
Consequently, univariate quasi-Poisson regression models were
used to find variables that were significantly associated with failure
rates. A multivariate analysis was then performed to identify the
variables significantly associated with failure rates. For model
selection, a deviance approach with a ‘‘drop-one’’ algorithm was
used [27]. An F-ratio statistic was calculated to compare models
with and without each of the discarded variables [28].
Results
In the systematic review search, we screened a total of 323
articles and identified 17 articles of which, after full-text reading,
12 articles were excluded (Figure 1). Table S2 indicates the reason
for exclusion of these articles. Therefore, a total of 5 systematic
reviews were included to serve as the database from which primary
articles were extracted [9,10,22,29,30]. Our final sample consisted
of 38 published clinical trials. The full list of references which
included primary articles is presented in Table S3. Figure 2 depicts
the flow diagram for inclusion of the primary articles. Three
articles dealt with 2 different prosthetic designs. They were thus
each considered as 2 different trials for the analysis, leading to a
total of 41 analyzable trials. The Kappa coefficient between
examiners (A.P. and O.F.) was 0.90 (CI95% [0.77–1.00])
demonstrating an almost prefect degree of agreement [31]. The
initial Poisson model (with the offset variable only) provided a
deviance equal to 161.20, which was much greater than the
degrees of freedom (equal to 40), suggesting a strong heterogeneity.
Descriptive data for the extracted trials are shown in Table 1. The
funding source was not reported in the majority of the trials (63%,
26/41). Taking into account all years together, the majority of the
trials were considered as having a risk of bias (66%, 27/41). The
reporting did not mention a statistical advisor in 30 trials (73%), and
almost all trials did not report the periodontal status of the patients
(83%, 34/41). Implant brands were dominated by one company
( 5 9 % ,2 4 / 4 1 ) ,a n dS w e d e n ,t h ec o m p a n y ’ so r i g i n a lc o u n t r y ,w a st h e
most common country among the corresponding authors (24%, 10/
41). In our sample, 22% of the trials (9/41) were published in non
indexed journalsfor the year prior to publication. A conflict of interest
statement was disclosed in 2 trials. In both statements, the authors
reported that they had no conflict of interest.
Figure 3 indicates that the annual estimated percentages of
failures ranged from 0 to 5.56 (CI95% [0.00–14.76]). The mean
annual failure rate of the trials was estimated at 1.09%.(CI95%
[0.84–1.42]). The mean annual failure rate calculated for the non-
industry trials was equal to 2.73% (CI95% [1.14–6.55], i.e. almost 3
times the rate for all the trials.
As shown in Table 2, the outcomes of the univariate quasi-Poisson
regression models indicate a significant effect of the prosthetic design
(p=0.023) and the source of funding (p=0.005). Compared with
non-industry associated trials, both industry associated trials as well as
trials where the sponsorship was unknown were more likely to report
lower annual failure rates, showing ORs of 0.32 (CI95% [0.17–0.60])
and 0.37 (CI95% [0.21–0.63]), respectively. The multivariate analysis
yields to the selection of publication age (p=0.002) and funding
source (p,0.001) in the final mode. Given data on funding source,
the annual failure rate was 1.12 times higher for a one-year old
increase in the publication age. Given information on study age,
industry associated (OR=0.21; CI95% [0.12–0.38]) and unknown
funding source (OR=0.33; (CI95% [0.21–0.51]) trials had lower
annual failure rates as compared with non-industry associated trials.
Discussion
The main outcome of this study indicates that the funding
sources have a significant effect on the annual rate of failure of
dental implants. Given the publication age and when controlling
for other factors, the annual failure rate for industry associated
trials is significantly lower as compared with non-industry
associated trials (OR=0.21). These findings add significant new
information to the field of dentistry and contribute to the body of
Sponsorship in Dental Implant
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research outcomes [16,32].
Interestingly, the multivariate analysis shows that trials where
the financial funding source was not reported had an even lower
probability of failure than industry associated trials (OR=0.33).
This outcome is hard to interpret. The trials belonging to this
‘‘unknown’’ category are probably the most biased. The authors
deliberately did not report the sponsor. It may indicate that
industry involvement in a clinical study implies some quality
control to reduce bias in order to maintain company reputation.
On the other hand, it is noteworthy that 63% of the trials included
in the analysis did not report the funding source. This imbalance
between sample size of disclosed and undisclosed funding sources
(15/26) may have influenced the statistical results. The multivar-
iate analysis also indicates that the annual rate of failure increases
with the article seniority following the date of publication. This
outcome may correspond to an improvement in dental implant
therapies.
Leaving aside the lack of transparency of the funding source, a
number of common weaknesses were identified in the trials’re-
porting. Lack of inclusion/exclusion criteria, inadequate blinding,
and lack of drop-out rates were common, leading to the
Figure 1. Flowchart of systematic review selection.
doi:10.1371/journal.pone.0010274.g001
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methodological quality assessment scale. Our intent was not to
evaluate the overall quality of the trial, which may imply the rating
of each individual feature aimed to reduce bias, but rather to
provide a snapshot of the risk of bias of each trial through three
items that focus on important aspects of study design. A statistician
was identified in only 27% of the trials, rendering the analysis of
the data questionable. In addition, the periodontal status of the
subjects was reported in only 17% of the trials, although a
significant difference in mean peri-implant marginal bone loss
between patients with a history of periodontitis and periodontally
healthy subjects has been shown [33,34]. These weaknesses
suggest that the relevance of the annual failure rates given by
these types of trials must be interpreted with caution. However,
taken together, these factors could not significantly overcome the
impact of the funding source on the annual failure rate when
included in the multivariate analysis.
We used the impact factor as the main journal characteristic
because the quality of the reporting may vary with the journal. In
our sample, only peer-reviewed journals were included. The
regression models did not disclose an association between journal
impact factors and the annual rate of failure. This finding is similar
Figure 2. Flowchart of the primary article selection.
doi:10.1371/journal.pone.0010274.g002
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sponsorship bias in pharmaceutical trials [16].
Our study is the first, to our knowledge, investigating the impact
of sponsorship in the field of dentistry. This study has several
strengths. We used dental implant therapy, a model where the
market is very competitive as highlighted by the number of
implant brands included in the sample. Thus, our findings may be
generalizable to other dental products and devices within
competitive markets, such as in orthodontics, periodontology or
prosthetic dentistry. In addition, the consequences of the
widespread use of dental implants have an effect on the health
and well-being of the entire population, due to the impact on the
extraction indications of the practitioners and on the health-policy
aiming to reimburse dental therapies. Our study used the
framework of a systematic method to identify the trials, and the
annual failure rate as an objective measurable comparator. We
decided to use the survival rate as the main variable and not the
success rate because biological and technical complications were
independently recorded in some systematic reviews [7,8]. The
overlap of biological and technical complications, due to the fact
that one implant may have more than one complication, precludes
any pooled estimate of success rate. Consequently, the number of
systematic reviews using the survival rate as the main variable
[9,10,22,29,30] was higher than those available using the success
rate [30,35].
The primary limitation of our study is the weak transparency of
the financial support reporting of the trials included in the analysis.
It may be assumed that among the 26 trials where the sponsorship
was categorized as ‘‘unknown’’, part of them were in fact partially
supported by industry. For example, it is well-known that
companies sometimes provide dental implants for free in order
to evaluate their products. This may lead to publications and
financial support of the companies in a communication plan where
the authors are involved.
This ‘‘ghost’’ funding source may affect reporting objectivity. In
addition, it was not possible to explore the relationship between a
potential sponsor and the authors of the articles, because a conflict
of interest statement was mentioned in only 2 out 41 trials.
Consequently, it may be assumed that our study underestimated
the number of industry associated trials.
Second, our sample is not exhaustive of all the studies dealing
with dental implant survival. Systematic reviews were our
source of trials because they are presumed to be objective.
When done well, they are considered the highest level of
evidence for medical decision making [36]. The results and
conclusions of systematic reviews are often cited, and are the
cornerstones of the decision making process when determining
whether or not to insert an implant for tooth replacement.
Thus, one can assume that the articles included in these reviews
are those responding the best to high quality standards.
Interestingly, in our study, 2 out of the 5 selected systematic
reviews did not disclose their funding source [10,29]. In the
remaining 3 included systematic reviews, 2 of them declared no
conflict of interest [9,22].
Third, we were unable to pool meaningful evidences about
factors that might be associated with the rate of failure. We thus
speculated on variables identifiable in the sample assuming that
they could affect the annual rate and be competitive with the
sponsorship bias. Among them, the prosthetic design was regularly
reported, and we hypothesized that it could be one of the most
influential cofactors. We thus excluded trials involving fully
edentulous patients in attempt to reduce the heterogeneity of the
prosthetic design. Our hypothesis turned out to be strengthened by
the significant effect of this variable in the univariate analysis
(p=0.023). However, the prosthetic design was not significant in
the multivariate models, meaning that, even if strong, this factor
could not overcome the funding source variable. Based on the
basic principle that the magnitude of the treatment effect is
influenced by the sample size, we also speculated that the sample
size, i.e. the number of implants per trial, may have an effect on
the rate of failure. Indeed, this variable did not show a significant
effect in the present analysis.
Table 1. Sample characteristics.
Characteristics Category Total n=41
Age of publication, tertiles 4–10 31 (76%)
11–15 9 (22%)
.15 1 (2%)
Impact factors, tertiles Not indexed 9 (22%)
0.52–1.09 8 (19%)
1.10–1.67 15 (37%)
1.68–2.24 9 (22%)
Corresponding author country USA 4 (10%)
Belgium 5 (12%)
Sweden 10 (24%)
Switzerland 5 (12%)
Italy 2 (5%)
England 2 (5%)
Germany 3 (7%)
Canada 2 (5%)
Others 8 (20%)
Study design Retrospective 10 (25%)
Prospective 31 (75%)
Quality assessment Low risk of bias 14 (34%)
Risk of bias 27 (66%)
Statistical advisor Yes 11 (27%)
No 30 (73%)
Prosthetic design IS-SC 18 (44%)
IS-FPD 15 (36%)
ITS-FPD 8 (20%)
Periodontal status report Yes 7 (17%)
No 34 (83%)
Total number of implants, tertiles 10–347 38 (93%)
348–685 2 (5%)
686–1022 1(2%)
Number of failures, tertiles 0–19 37 (90%)
20–39 2 (5%)
40–58 2 (5%)
Implant brand Straumann 8 (19%)
Astra Tech 3 (7%)
Nobel Biocare 24 (59%)
Others 6 (15%)
Funding source Industry 2 (5%)
Industry associated 9 (22%)
Non industry 4 (10%)
Unknown 26 (63%)
doi:10.1371/journal.pone.0010274.t001
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doi:10.1371/journal.pone.0010274.g003
Table 2. Regression quasi-Poisson univariate and multivariate models of the effects of independent variables on the annual failure
rate of dental implants.
Category Univariate Quasi-Poisson Multivariate Quasi-Poisson
OR CI 95% p-value OR CI 95% p-value
Study Age 1.07 [0.98–1.16] 0.085 1.12 [1.06–1.19] 0.002
Number of Implants 1.00 [0.99–1.00] 0.424
Impact Factor 0.90 [0.61–1.33] 0.549
Periodontal Status Report No 1 –
Yes 0.90 [0.33–2.45] 0.812
Prosthetic Design ITS-FPD 1 –
IS-FPD 0.56 [0.34–0.91]
IS-SC 0.34 [0.15–0.77] 0.023
Quality Score LRB 1 –
RB 0.81 [0.47–1.41] 0.427
Statistical Advisor No 1 –
Yes 1.54 [0.95–2.50] 0.082
Funding Source Non-Industry Associated 1 – 1
Industry Associated 0.32 [0.17–0.60] 0.21 [0.12–0.38]
Unknown 0.37 [0.21–0.63] 0.005 0.33 [0.21–0.51] ,0.001
doi:10.1371/journal.pone.0010274.t002
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were included in the present analysis had an observational design
and not an experimental design. It is well known that
observational studies are more vulnerable to methodological
problems and must be critically interpreted. They are prone to
bias and confounding. Therefore, the real world mean annual
failure rate is if anything likely higher than that found here for the
non-industry trials (2.73%), given that the study designs have a
high risk of bias.
The outcomes of this study strongly suggest the need for more
transparency in the sponsorship of trials dealing with dental
implant therapy. In the future, details on the financial source
should be clearly reported. Dental publications should include at
least a conflict of interest statement. So far, only one of the journals
quoted in the present study has recently adopted such a statement.
This is a first step towards increasing the transparency of the trial
funding sources. Our results fully encourage editors of dental
journals and authors of future studies in dentistry to be informed of
certain initiatives that have been proposed to reduce the
sponsorship bias in the biomedical research as well as in the
Health Economics studies [15,37]. Ultimately, more studies,
including well conducted randomized clinical trials, are needed
to identify potentially influential factors that can affect the rate of
failure of the dental implants. Efforts should be made to increase
the methodological quality of the reporting. So far, only 2 out of 9
dental journals involved in our sample (Journal of Clinical
Periodontology and Clinical Oral Implant Research) have adopted
the CONSORT guidelines [38]. The conclusions of the present
study therefore strongly encourage the implementation of the
CONSORT statements in the field of dental clinical research.
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